OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Addex Therapeutics Ltd/  CH0029850754  /

Cboe Europe CXE
07/10/2024  14:42:24 Chg. - Volume Bid09:38:05 Ask17:02:47 Market Capitalization Dividend Y. P/E Ratio
0.070CHF - 40,530
Turnover: 2,861.620		 -Bid Size: - -Ask Size: - 13.08 mill.CHF - -
GlobeNewswire 27/08 Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Coll...
GlobeNewswire 22/07 Addex’s Partner Discontinues ADX71149 development in Epilepsy
GlobeNewswire 15/07 Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International ...
GlobeNewswire 12/07 Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
GlobeNewswire 01/07 Addex Shareholders Approve All Resolutions at Annual General Meeting
GlobeNewswire 06/06 Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05/06 Addex Convenes Annual General Meeting 2024
GlobeNewswire 31/05 Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire 08/05 Addex to Present at Bio€quity Europe 2024
GlobeNewswire 29/04 Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
GlobeNewswire 19/04 Addex to Present at the Swiss Biotech Day 2024
GlobeNewswire 18/04 Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 11/04 Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire 03/04 Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire 14/03 Addex to Present at the Bio-Europe Spring 2024 Conference
GlobeNewswire 31/01 Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire 09/01 Addex to Present at the Swiss Equities Baader Conference
GlobeNewswire 05/01 Addex to Present at Biotech Showcase™ 2024
GlobeNewswire 14/12/2023 Addex Creates Treasury Shares
GlobeNewswire 29/11/2023 Addex Reports Q3 2023 Financial Results and Provides Corporate Update
GlobeNewswire 28/11/2023 Addex Convenes Extraordinary General Meeting
GlobeNewswire 23/11/2023 Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
GlobeNewswire 14/11/2023 Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients
GlobeNewswire 08/11/2023 Addex Regains Nasdaq Listing Compliance
GlobeNewswire 02/11/2023 Addex Announces Participation in the Bio-Europe 2023 Conference